Debt (Tables)

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Balances of Long-term debt, net

Long-term debt, net consists of the following:

	September 30,		December 31,
	2021		2020
Liability component - principal	$	200,000	$	200,000
Exit fee		—		14,000
Unamortized debt discount associated with the exit fee, debt financing costs and discount with warrant financing (see note 13)		(7,931)		(19,750)
Liability component - net carrying value		192,069		194,250
Less current portion		(2,000)		—
Long term debt, net	$	190,069	$	194,250

Future Minimum Payments to Long Term Debt

Future minimum payments relating to long term debt, net as of September 30, 2021 for the periods indicated below consists of the following:

Years ending December 31,
2021 (excluding the nine months ended September 30, 2021)	$	500
2022		2,000
2023		2,000
2024		20,000
2025		20,000
Thereafter		155,500
Total	$	200,000

Interest Expense Related to OrbiMed Loan and CRG Loan

Interest expense related to the Company’s long term debt, net, which is included in interest expense, net in the unaudited condensed consolidated statements of operations and comprehensive income (loss), consists of the following:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Interest on principal balance	$	5,030	$	6,655	$	18,122	$	19,549
Amortization of deferred financing costs		459		340		1,820		1,020
Total term loan interest expense	$	5,489	$	6,995	$	19,942	$	20,569